Professor, MD, chair of DBCG, breast cancer researcher, Aarhus University Hospital, Experimental Clinical Oncology, Danish Centre for Particle Therapy.
Aarhus, Danmark
Joined May 2019
- Tweets109
- Following258
- Followers534
- Likes469
Birgitte Offersen retweeted
I am SO excited about this!!! 🤩
We've put together a brilliant (in my humble opinion😉) line-up of speakers to discuss the challenges facing clinical re-irradiation. Please join us, it's going to be so much fun!
#ReIrradiation #medphys #radonc
Join the Reirradiation Webinar Series. Our experts will unravel complexities of #reirradiation throughout 8 sessions, running from Oct 2023 to May 2024.
📅 Save the Date: 1st session kicks off on 26 Oct.
It's FREE!
👉 Programme and Registration: bit.ly/3RZr2ci
#RadOnc
Birgitte Offersen retweeted
Finally super #DESTINYbreast03 data presented at #ESMO21 are out in @NEJM: #TrastuzumabDeruxtecan is the new standard 2nd line therapy in #HER2+ advanced #BreastCancer..congrats (and thanks) @JavierCortesMD et al for this terrific trial!
@OncoAlert #bcsm
nejm.org/doi/full/10.1056/NE…
Birgitte Offersen retweeted
We discussed about tailoring indications, target volume definition and selection and dose/fractionation in #breastcancer at the 4th Assisi Think Thank Meeting! Great to be back live again after so long! #ATTM #Oncoalert #radonc
Birgitte Offersen retweeted
The 4th Assisi Think Tank meeting on research challenges in #breastcancer endorsed by @ESTRO_RT Finally in-person brainstorming event with an amazing Faculty @OncoAlert #OncoAlert – at Assisi, Umbria
Birgitte Offersen retweeted
The #Radiotherapy #guidelines ☢️from the Danish head and neck cancer group #DAHANCA 🇩🇰 can now be download from the #greenjournal 😃👍🏼 #radonc #sharingiscaring ➡️ thegreenjournal.com/article/… ⬅️ – at Copenhagen, Denmark
Birgitte Offersen retweeted
Fantastisk nyhed 👏
Velkommen til Dansk Forskningscenter for Kræftkirurgi - Et stærkt nationalt samarbejde til gavn for alle danske kræft patienterne.
Vi glæder os meget til samarbejdet 😀 #dksund #dkforsk
Nyt forskningscenter for kræftkirurgi ser nu dagens lys med 20 mio.kr. støtte fra #knækcancer 🙌❤️
Centeret skal bl.a. udvikle og forbedre kirurgiske metoder, så flere bliver i stand til at tåle en kræftoperation.
#dksund #dkforsk
cancer.dk/nyheder/20-mio-kr-…
Birgitte Offersen retweeted
A must-to-be attended debate that I’ve the honour to chair @ESTRO_RT #ESTRO2021 with excellent #breastcancer experts @BOffersen @i_ratosa See you in Madrid and online soon! @OncoAlert #OncoAlert @AiroBreast
Should the majority of radiation treatments after breast conserving surgery consist of maximum 5 fractions? Join the #clinicaldebate #ESTRO2021 on 28 August 👉 bit.ly/3lXgz1e
Birgitte Offersen retweeted
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal #BreastCancer @OncoAlert @AiroBreast #OncoAlert nejm.org/doi/full/10.1056/NE…
Birgitte Offersen retweeted
vi er og bliver en bananrepublik, når det kommer til rygeforbyggelse her i Danmark... Hvis nogen var i tvivl #dkpol
#BigTobacco is invited to advise Danish Parliament Tax Committee about tobacco prevention 🤯
This clearly breaks @WHO convention (FCTC 5.3)
#dkpol @FCTCofficial
ft.dk/udvalg/udvalgene/SAU/k…
Birgitte Offersen retweeted
All the #ASTRO20 tweets make me rather envious. I’d have loved to attend, but the $1,235 registration fee makes it impossible. I’m sure it’s pocket money for a US private practice #radonc, but it’s like 1/3 of my monthly salary. How about an academic non-member option @ASTRO_org?
Birgitte Offersen retweeted
"TARGIT-A does not provide sufficient evidence to conclude that IORT is superior to no RT and, in the absence of supportive evidence, IORT should not be used
outside of clinical trials"
@petersasieni & Elinor Sawyer nicely summarize why TARGIT-A is NOT practice-changing!🧐
Intraoperative radiotherapy for early breast cancer — insufficient evidence to change practice. IORT has not been shown to be superior to no RT | Nature Reviews Clinical Oncology @SorenBentzen @ASTRO_org nature.com/articles/s41571-0…
Birgitte Offersen retweeted
Dear Astro - read the paper and retweet because you got it wrong: Targit miss the targit and the treatment is inferior
I am lost for words! Seriously! Those who know me, know that this doesn't happen that often.
Let me just note, that the conclusions from the TARGIT IORT trial are controversial, to say the least🤨
I do find it ironical, this uncritical summary is tweeted by @ASTRO_org
Birgitte Offersen retweeted
I was lost for words too as I read ASTRO's tweet 🥴
I am lost for words! Seriously! Those who know me, know that this doesn't happen that often.
Let me just note, that the conclusions from the TARGIT IORT trial are controversial, to say the least🤨
I do find it ironical, this uncritical summary is tweeted by @ASTRO_org
Birgitte Offersen retweeted
First two H&N cancer patients randomised in the Danish #DAHANCA35 trial of proton vs photon radiotherapy: NTCP models calculate risks of swallowing difficulties/dry mouth. Inclusion if reduction >5%. Results expected in 2024. @DCPTprotons #dahanca @Rigshospitalet @DCCC_RT
Birgitte Offersen retweeted
Another MAJOR PROOF of the effectiveness of #HPV #Vaccination @NEJM
bit.ly/2HDGXei
"Compared to unvaccinated women, adjusted incidence rate ratio of 0.12 (0.00-0.34) & 0.47 (0.27-0.75) in women vaccinated before 17y & 17-30y."
Now waiting for data on oropharynx cancer
Birgitte Offersen retweeted
👍 Brita Singers Sørensen er ny professor på @DCPTprotons og skal især udvide det internationale samarbejde indenfor partikelterapi bit.ly/32APsiB @AarhusUni @DCCCcancer @cancer_dk #dkvid
Birgitte Offersen retweeted
Et ønske om at styrke det nationale netværk inden for anal cancer begyndte i 2017 med DCCC-støttet netværk, som har startet et nordisk samarbejde. I 2021 afholdes den første internationale anal cancer konference, IMACC. Læs historien bag: dccc.dk/nyheder/styrket-inte… #dkforsk #sundpol
